Cambridge Healthtech Institute’s 16th Annual
Engineering the Next Generation of Bispecific Antibodies
Introducing Novel Functionality and Constructs
13 November 2025
Strategies for engineering bi-, tri-, and multi-specific antibodies and emerging platform technologies will be premiered at Cambridge Healthtech Institute's Sixteenth Annual Engineering the Next Generation of Bispecific Antibodies track at PEGS Europe. This area is demonstrating tremendous progress and this forum will survey the current landscape and highlight emerging results in increasing targeting, efficacy, and specificity.
Coverage will include, but is not limited to:
- Determining and evaluating developability parameters
- Advancing co-stimulatory multispecific antibodies
- Designing novel T-cell engaging bispecific antibodies
- Engineering conditionally active multispecific antibodies
- Demonstrating effector cell redirection
- Exploring a diverse array of new constructs and approaches
The deadline for priority consideration is 28 March 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: